Chemokines as immune mediators of liver diseases related to the metabolic syndrome

Digestive Diseases

Volumn 28, Issue 1, 2010, Pages 192-196

  Berres, Marie Luise ^a   Nellen, Andreas ^a   Wasmuth, Hermann E ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Chemokines; Fatty liver; Immune cell recruitment; Non alcoholic steatohepatitis; Stellate cells

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SCAVENGER RECEPTOR; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ADIPOSE TISSUE; CELL INFILTRATION; FATTY LIVER; GENE DELETION; HEPATITIS; HUMAN; IMMUNOPATHOGENESIS; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIVER INJURY; MACROPHAGE MIGRATION; MEDIATOR RELEASE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW;

ANIMALS; CHEMOKINES; DISEASE MODELS, ANIMAL; FATTY LIVER; HUMANS; INFLAMMATION; LIVER; LIVER DISEASES; METABOLIC SYNDROME X; MICE; MICE, KNOCKOUT; RECEPTORS, CHEMOKINE; RECEPTORS, SCAVENGER;

EID: 77952565960     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000282085     Document Type: Review

References (30)

1. Charo IF, Ransohoff RM: The many roles of chemokines and chemokine receptors in inf lammation. N Engl J Med 2006;354:610-621.
2. Mantovani A, Bonecchi R, Locati M: Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 2006;6:907-918.
3. Farrell GC, Larter CZ: Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43:S99-S112.
4. Pease JE, Horuk R: Chemokine receptor anta gonists: part 1. Expert Opin Ther Pat 2009;19:39-58.
5. Pease JE, Horuk R: Chemokine receptor antagonists: part 2. Expert Opin Ther Pat 2009;19:199-221.
6. Lalor PF, Faint J, Aarbodem Y, Hubscher SG, Adams DH: The role of cytokines and chemokines in the development of steatohepatitis. Semin Liver Dis 2007;27:173-193.
7. Kruglov EA, Nathanson RA, Nguyen T, Dranoff JA: Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. Am J Physiol Gastrointest Liver Physiol 2006;290:G765-G771.
8. Wasmuth HE, Zaldivar MM, Berres ML, Werth A, Scholten D, Hillebrandt S, Tacke F, Schmitz P, Dahl E, Wiederholt T, Heller- brand C, Berg T, Weiskirchen R, Trautwein C, Lammert F: The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection. J Hepatol 2008;48:208-215.
9. Wasmuth HE, Lammert F, Zaldivar MM, Weiskirchen R, Hellerbrand C, Scholten D, Berres ML, Zimmermann H, Streetz KL, Tacke F, Hillebrandt S, Schmitz P, Keppeler H, Berg T, Dahl E, Gassler N, Friedman SL, Trautwein C: Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans. Gastroenterology 2009;137:309-319, 319.e1-319.e3.
10. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH: Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 1999;163:6236-6243.
11. Schrage A, Wechsung K, Neumann K, Schumann M, Schulzke JD, Engelhardt B, Zeitz M, Hamann A, Klugewitz K: Enhanced T cell transmigration across the murine liver sinusoidal endothelium is mediated by transcytosis and surface presentation of chemokines. Hepatology 2008;48:1262-1272.
12. Li Z, Soloski MJ, Diehl AM: Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 2005;42:880-885.
13. Wynn TA: Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004;4:583-594.
14. Palmer C, Corpuz T, Guirguis M, O'Toole S, Yan K, Bu YM, Jorgenson J, Talbot M, Lloyd A, Zekry A: The effect of obesity on intrahepatic cytokine and chemokine expression in chronic hepatitis C infection. Gut 2009, E-pub ahead of print.
15. Muhlbauer M, Bosserhoff AK, Hartmann A, Thasler WE, Weiss TS, Herfarth H, Lock G, Scholmerich J, Hellerbrand C: A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 2003;125:1085-1093.
16. Wobser H, Dorn C, Weiss TS, Amann T, Bollheimer C, Buttner R, Scholmerich J, Hellerbrand C: Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate Cells. Cell Res 2009;19:996-1005.
17. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M: MC P-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006;116:1494-1505.
18. Holt AP, Haughton EL, Lalor PF, Filer A, Buckley CD, Adams DH: Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology 2009;136:705-714.
19. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW Jr: CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006;116:115-124.
20. Deng ZB, Liu Y, Liu C, Xiang X, Wang J, Cheng Z, Shah SV, Zhang S, Zhang L, Zhuang X, Michalek S, Grizzle WE, Zhang HG: Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology 2009;50:1412-1420.
21. Tamura Y, Sugimoto M, Murayama T, Ueda Y, Kanamori H, Ono K, Ariyasu H, Akamizu T, Kita T, Yokode M, Arai H: Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice. Arterioscler Thromb Vasc Biol 2008;28:2195-2201.
22. Abiru S, Migita K, Maeda Y, Daikoku M, Ito M, Ohata K, Nagaoka S, Matsumoto T, Takii Y, Kusumoto K, Nakamura M, Komori A, Yano K, Yatsuhashi H, Eguchi K, Ishibashi H: Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int 2006;26:39-45.
23. Bonacchi A, Petrai I, Defranco RM, Lazzeri E, Annunziato F, Efsen E, Cosmi L, Romagnani P, Milani S, Failli P, Batignani G, Liotta F, Laffi G, Pinzani M, Gentilini P, Marra F: The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 2003;125:1060-1076.
24. Locati M, Torre YM, Galliera E, Bonecchi R, Bodduluri H, Vago G, Vecchi A, Mantovani A: Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines. Cytokine Growth Factor Rev 2005;16:679-686.
25. McKimmie CS, Fraser AR, Hansell C, Gutierrez L, Philipsen S, Connell L, Rot A, Kurowska-Stolarska M, Carreno P, Pruenster M, Chu CC, Lombardi G, Halsey C, McInnes IB, Liew FY, Nibbs RJ, Graham GJ: Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol 2008;181:3353-3363.
26. Jamieson T, Cook DN, Nibbs RJ, Rot A, Nixon C, McLean P, Alcami A, Lira SA, Wiekowski M, Graham GJ: The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol 2005;6:403-411.
27. Whitehead GS, Wang T, DeGraff LM, Card JW, Lira SA, Graham GJ, Cook DN: The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity. Am J Respir Crit Care Med 2007;175:243-249.
28. Martinez de la Torre Y, Buracchi C, Borroni EM, Dupor J, Bonecchi R, Nebuloni M, Pasqualini F, Doni A, Lauri E, Agostinis C, Bulla R, Cook DN, Haribabu B, Meroni P, Rukavina D, Vago L, Tedesco F, Vecchi A, Lira SA, Locati M, Mantovani A: Protection against inflammation- and autoantibody- caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci USA 2007;104:2319-2324.
29. Wiederholt T, von Westernhagen M, Zaldivar MM, Berres ML, Schmitz P, Hellerbrand C, Müller T, Berg T, Trautwein C, Wasmuth HE: Genetic variations of the chemokine scavenger receptor D6 are associated with liver inflammation in chronic hepatitis C. Hum Immunol 2008;69:861-866.
30. Berres ML, Trautwein C, Zaldivar MM, Schmitz P, Pauels K, Lira SA, Tacke F, Wasmuth HE: The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo. Biol Chem 2009;390:1039-1045.